Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Radcliffe Group Announces the Release of Radcliffe-CME

Radcliffe Group Ltd
Posted on: 09 Feb 18
Radcliffe Group Announces the Release of Radcliffe-CME The Radcliffe Group announces the release of their new online eLearning platform for continuing medical education, Radcliffe-CME.

PR Newswire

LONDON, Feb. 8, 2018

LONDON, Feb. 8, 2018 /PRNewswire/ -- It has been a busy start to 2018 for the Radcliffe Group, who today announced the release of their new online eLearning platform for continuing medical education, Radcliffe-CME.

Radcliffe-CME specialises in CME content created especially for cardiovascular professionals and will offer physicians access to independent and accredited medical education programmes through the provision of high-quality educational content and dedicated learning outcomes.

The first release includes a brand-new course on Utilizing NOAC's in NVAF patients with PCI and is available now, with a choice of three languages: English, Spanish, and German.

For further details please visit: or contact

About the Radcliffe Group:

A specialist provider of cardiometabolic content, The Radcliffe Group offers physicians access to content through a variety of media formats stemming from industry-led peer-reviewed research journals, video interviews, live events, and online medical courses.

They continually seek to improve experiences for our learners. As innovators in digital learning, we are passionate about eLearning and are a leading educational platform for medical professionals around the world.

Related Files

CME press release.pdf

Related Images

Radcliffe Group Ltd Logo
An image of the Radcliffe Group logo

Radcliffe CME Logo
Radcliffe Continuing Medical Education Logo

Radcliffe Group Icon
The Radcliffe Group "R" Icon image

Related Links

Radcliffe CME

Radcliffe Group

View original content with multimedia:

SOURCE Radcliffe Group Ltd

PR Newswire

Last updated on: 09/02/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.